Stocks Health care IMRN
NASDAQ · Health careImmuron Ltd (IMRN)
We have not processed filings for Immuron Ltd yet. This page fills in on its own once we have read them.
What Immuron Ltd does
Immuron Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IMRN.
Latest SEC filings
What Immuron Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026Annual report (foreign issuer) 20-F · period to June 30, 2026
- September 24, 2026
- September 22, 2026
- September 4, 2026
- August 28, 2026
- August 19, 2026
- August 13, 2026
- July 27, 2026
- July 21, 2026
- July 20, 2026
Questions about IMRN
What does Immuron Ltd do?
Immuron Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IMRN.
When did Immuron Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on September 24, 2026. It covers the period to June 30, 2026.
Similar companies
Compare IMRN with
Follow IMRN
Get an email when Immuron Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow IMRN: get an email when it filesWhere the numbers come from
Financial figures are the values Immuron Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.